Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients

Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis

(2013) Anna Maria Malfitano et al.   PLoS One

Neuroprotective agents: Cannabinoids

(2011) A.J. Sánchez et al.   CLINICAL IMMUNOLOGY

The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis

(2011) Bernd C. Kieseier   CNS DRUGS

Determinants of interferon β efficacy in patients with multiple sclerosis

(2011) Joep Killestein et al.   Nature Reviews Neurology

Interaction between cytokines, cannabinoids and the nervous system

(2010) Lucie Jean-Gilles et al.   IMMUNOBIOLOGY

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors

(2010) Maria Teresa Cencioni et al.   PLoS One

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Plasma endocannabinoid levels in multiple sclerosis

(2009) L. Jean-Gilles et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The Endocannabinoid System and Multiple Sclerosis

(2008) David Baker et al.   CURRENT PHARMACEUTICAL DESIGN

Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis

(2008) M Di Filippo et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Role of CB2 receptors in neuroprotective effects of cannabinoids

(2008) Javier Fernández-Ruiz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Predictive markers for response to interferon therapy in patients with multiple sclerosis

(2008) S. Malucchi et al.   NEUROLOGY